business
What's the Better Dividend Stock Today: AbbVie or Pfizer?
Key takeaways
- PFE ABBV Abb Vie (NYSE: ABBV) and Pfizer (NYSE: PFE) are two top healthcare stocks, and they re investments that can generate a ton of dividend income for your portfolio.
- Abb Vie, which yields 3.2%, has been a dividend growth beast for decades and has been doing a good job of growing its business even after its top-selling drug Humira lost patent protection.
- Our team just released a report on a little-known company, called an "Indispensable Monopoly," providing the critical technology Nvidia and Intel both need.
PFE ABBV Abb Vie (NYSE: ABBV) and Pfizer (NYSE: PFE) are two top healthcare stocks, and they re investments that can generate a ton of dividend income for your portfolio.
Abb Vie, which yields 3.2%, has been a dividend growth beast for decades and has been doing a good job of growing its business even after its top-selling drug Humira lost patent protection. It has proven to be a good long-term dividend investment to hang on to.
Will AI create the world s first trillionaire? Our team just released a report on a little-known company, called an "Indispensable Monopoly," providing the critical technology Nvidia and Intel both need. Continue »
Article preview — originally published by Yahoo Finance. Full story at the source.
Read full story on Yahoo Finance →
More top stories
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop